Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRMP2 and voltage-gated ion channels: potential roles in neuropathic pain
Lindsey A. Chew, Rajesh Khanna
Neuronal Signaling (2018) Vol. 2, Iss. 1
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Small molecule targeting NaV1.7 via inhibition of CRMP2-Ubc9 interaction reduces pain-related outcomes in a rodent osteoarthritic model
Sara Hestehave, Heather N. Allen, Kimberly Gómez, et al.
Pain (2024)
Closed Access | Times Cited: 8
Dysregulation of CRMP2 Post-Translational Modifications Drive Its Pathological Functions
Aubin Moutal, Katherine A. White, Aude Chefdeville, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 10, pp. 6736-6755
Open Access | Times Cited: 68
Contribution of the dihydropyrimidinase-like proteins family in synaptic physiology and in neurodevelopmental disorders
Florence Desprez, Dévina C. Ung, Patrick Vourc’h, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 19
Rhodojaponin VI indirectly targets Cav2.2 channels via N-ethylmaleimide-sensitive fusion protein to alleviate neuropathic pain
Keliang Chen, Tao Wang, Yong Li, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 3, pp. 1326-1336
Open Access | Times Cited: 17
Inhibition of the Ubc9 E2 SUMO-conjugating enzyme–CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain
Liberty François‐Moutal, Erik T. Dustrude, Yue Wang, et al.
Pain (2018) Vol. 159, Iss. 10, pp. 2115-2127
Open Access | Times Cited: 57
Sculpting excitable membranes: voltage-gated ion channel delivery and distribution
Sidharth Tyagi, Grant P. Higerd‐Rusli, Elizabeth J. Akin, et al.
Nature reviews. Neuroscience (2025)
Closed Access
Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission
Jie Yu, Aubin Moutal, Angie Dorame, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 7, pp. 5241-5255
Open Access | Times Cited: 43
Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in chronic constriction injury (CCI) rats
Jiahe Li, Harrison J. Stratton, Sabina A. Lorca, et al.
Channels (2022) Vol. 16, Iss. 1, pp. 1-8
Open Access | Times Cited: 19
Intranasal CRMP2-Ubc9 inhibitor regulates NaV1.7 to alleviate trigeminal neuropathic pain
Santiago Loya‐López, Heather N. Allen, Paz Duran, et al.
Pain (2023)
Open Access | Times Cited: 12
CRMP2–Neurofibromin Interface Drives NF1-related Pain
Aubin Moutal, Li Sun, Xiaofang Yang, et al.
Neuroscience (2018) Vol. 381, pp. 79-90
Open Access | Times Cited: 37
Mining the Nav1.7 interactome: Opportunities for chronic pain therapeutics
Lindsey A. Chew, Shreya S. Bellampalli, Erik T. Dustrude, et al.
Biochemical Pharmacology (2019) Vol. 163, pp. 9-20
Open Access | Times Cited: 31
Reversal of Peripheral Neuropathic Pain by the Small-Molecule Natural Product Physalin F via Block of CaV2.3 (R-Type) and CaV2.2 (N-Type) Voltage-Gated Calcium Channels
Zhiming Shan, Song Cai, Jie Yu, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 6, pp. 2939-2955
Closed Access | Times Cited: 31
Studies on CRMP2 SUMOylation–deficient transgenic mice identify sex-specific Nav1.7 regulation in the pathogenesis of chronic neuropathic pain
Aubin Moutal, Song Cai, Jie Yu, et al.
Pain (2020) Vol. 161, Iss. 11, pp. 2629-2651
Open Access | Times Cited: 31
SUMOylation of synaptic and synapse‐associated proteins: An update
Jeremy M. Henley, Richard Seager, Yasuko Nakamura, et al.
Journal of Neurochemistry (2020) Vol. 156, Iss. 2, pp. 145-161
Open Access | Times Cited: 30
Intravitreal application of AAV-BDNF or mutant AAV-CRMP2 protects retinal ganglion cells and stabilizes axons and myelin after partial optic nerve injury
Wissam Chiha, Carole A. Bartlett, Steven Petratos, et al.
Experimental Neurology (2020) Vol. 326, pp. 113167-113167
Open Access | Times Cited: 28
The function of SUMOylation and its crucial roles in the development of neurological diseases
Xu Chen, Yuhong Zhang, Qiqi Wang, et al.
The FASEB Journal (2021) Vol. 35, Iss. 4
Closed Access | Times Cited: 26
Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces and prevents pain chronification in a mouse model of oxaliplatin-induced neuropathic pain
Kathryn Braden, Harrison J. Stratton, Daniela Salvemini, et al.
Neurobiology of Pain (2021) Vol. 11, pp. 100082-100082
Open Access | Times Cited: 26
Differential Effects of the G-Protein-Coupled Estrogen Receptor (GPER) on Rat Embryonic (E18) Hippocampal and Cortical Neurons
Kyle Pemberton, Martina Rosato, Cass Dedert, et al.
eNeuro (2022) Vol. 9, Iss. 4, pp. ENEURO.0475-21.2022
Open Access | Times Cited: 16
The Natural Flavonoid Naringenin Elicits Analgesia through Inhibition of NaV1.8 Voltage-Gated Sodium Channels
Yuan Zhou, Song Cai, Aubin Moutal, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 12, pp. 4834-4846
Closed Access | Times Cited: 29
The regulatory and enzymatic functions of CRMPs in neuritogenesis, synaptic plasticity, and gene transcription
Sheng‐Tao Hou
Neurochemistry International (2020) Vol. 139, pp. 104795-104795
Open Access | Times Cited: 26
Non-SUMOylated CRMP2 decreases NaV1.7 currents via the endocytic proteins Numb, Nedd4-2 and Eps15
Kimberly Gómez, Dongzhi Ran, Cynthia L. Madura, et al.
Molecular Brain (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Druggability of CRMP2 for Neurodegenerative Diseases
Rajesh Khanna, Aubin Moutal, Samantha Perez‐Miller, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 17, pp. 2492-2505
Closed Access | Times Cited: 22
Peptide and Peptidomimetic Inhibitors Targeting the Interaction of Collapsin Response Mediator Protein 2 with the N-Type Calcium Channel for Pain Relief
Samantha Perez‐Miller, Kimberly Gómez, Rajesh Khanna
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 7, pp. 1916-1936
Open Access | Times Cited: 2
A comprehensive review of traditional Chinese medicine in treating neuropathic pain
Naihua Hu, Jie Liu, Yong Luo, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37350-e37350
Open Access | Times Cited: 2
Chemical shift perturbation mapping of the Ubc9-CRMP2 interface identifies a pocket in CRMP2 amenable for allosteric modulation of Nav1.7 channels
Liberty François‐Moutal, David D. Scott, Samantha Perez‐Miller, et al.
Channels (2018) Vol. 12, Iss. 1, pp. 219-227
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top